NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -96.6% | 11 | -96.7% | 0.00% | -100.0% |
| Q3 2020 | $29,000 | 0.0% | 332 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $29,000 | +1350.0% | 332 | +1044.8% | 0.01% | – |
| Q1 2020 | $2,000 | -33.3% | 29 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $3,000 | 0.0% | 29 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | 0.0% | 29 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | 0.0% | 29 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | 0.0% | 29 | -17.1% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -96.8% | 35 | -96.8% | 0.00% | -94.7% |
| Q3 2018 | $94,000 | +14.6% | 1,091 | +0.6% | 0.02% | +11.8% |
| Q2 2018 | $82,000 | -2.4% | 1,084 | +4.8% | 0.02% | -5.6% |
| Q1 2018 | $84,000 | – | 1,034 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |